Davis Hugh M. bought ACRS

February 3, 2025 · Form 4 insider transaction

Davis Hugh M. bought 261,600 shares of Aclaris Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
261,600
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2025
Filing dateFebruary 4, 2025
Shares owned after261,600
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.

View the original Form 4 on SEC EDGAR